Medications for Epithelial Ovarian Carcinoma

3 results

  • elahere - mirvetuximab soravtansine injection, solution

    (Mirvetuximab Soravtansine)
    Immunogen, Inc.
    ELAHERE treats adults with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens.
    Medication Details
    Drug Interactions

  • lynparza - olaparib tablet, film coated

    (Olaparib)
    Astrazeneca Pharmaceuticals Lp
    Lynparza is a PARP inhibitor for adults with BRCA- or HRR-mutated cancers. Indicated for maintenance of ovarian cancer, adjuvant and metastatic breast cancer, maintenance of metastatic pancreatic cancer, and metastatic castration-resistant prostate cancer. Patient selection requires an FDA-approved companion diagnostic.
    Medication Details
    Drug Interactions

  • zejula - niraparib tablet, film coated

    (Niraparib)
    Glaxosmithkline Llc
    ZEJULA is a PARP inhibitor for maintenance treatment of adults with advanced or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who responded to platinum-based chemotherapy and have HRD-positive status or germline BRCA mutations.
    Medication Details
    Drug Interactions